FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054953072> ?p ?o ?g. }

• W2054953072 endingPage "286" @default.
• W2054953072 startingPage "275" @default.
• W2054953072 abstract "To evaluate UFT and cyclophosphamide (CTX) based metronomic chemotherapy plus celecoxib (CXB) for the treatment of patients with heavily pre-treated advanced gastrointestinal malignancies.Thirty-eight patients received 500 mg/mq(2) CTX i.v bolus on day 1 and, from day 2, 50 mg/day CTX p.o. plus 100 mg/twice a day UFT p.o. and 200 mg/twice a day CXB p.o. Tegafur, 5-FU, 5-FUH(2), GHB and uracil pharmacokinetics were assessed. Plasma vascular endothelial growth factor (VEGF), soluble VE-cadherin (sVE-C) and thrombospondin-1 (TSP-1) levels were detected by ELISA and real-time PCR of CD133 gene expression on peripheral blood mononuclear cell was also performed.Seventeen patients (45%) obtained stable disease (SD) with a median duration of 5.8 ms (range, 4.2-7.4). Median progression free survival (PFS) and overall survival (OS) were 2.7 ms (95% CI, 1.6-3.9 ms) and 7.1 ms (95% CI, 4.3-9.9 ms), respectively. No toxicities of grade >1 were observed. Pharmacokinetics of 27 patients (13/14, SD/progressive disease, PD) after the first treatment of UFT revealed that 5-FU AUC and C(max) values greater than 1.313 h × μg/ml and 0.501 μg/ml, respectively, were statistically correlated with stabilization of disease and prolonged PFS/OS. VEGF and sVE-C plasma levels were greater in the PD group when compared to SD group. CD133 expression increased only in the PD patients.Metronomic UFT and CTX with CXB in heavily pre-treated gastrointestinal patients were well tolerated and associated with interesting activity. Potential predictive pharmacokinetic parameters and pharmacodynamic biomarkers have been found." @default.
• W2054953072 created "2016-06-24" @default.
• W2054953072 creator A5003913815 @default.
• W2054953072 creator A5007823301 @default.
• W2054953072 creator A5010799165 @default.
• W2054953072 creator A5022695721 @default.
• W2054953072 creator A5025020524 @default.
• W2054953072 creator A5025413217 @default.
• W2054953072 creator A5033055161 @default.
• W2054953072 creator A5046601140 @default.
• W2054953072 creator A5047673996 @default.
• W2054953072 creator A5054413273 @default.
• W2054953072 creator A5058514609 @default.
• W2054953072 creator A5061818416 @default.
• W2054953072 creator A5064835475 @default.
• W2054953072 creator A5068055005 @default.
• W2054953072 creator A5077089876 @default.
• W2054953072 creator A5078071353 @default.
• W2054953072 creator A5083540572 @default.
• W2054953072 creator A5083693387 @default.
• W2054953072 creator A5089467403 @default.
• W2054953072 creator A5090113174 @default.
• W2054953072 date "2012-03-02" @default.
• W2054953072 modified "2023-09-26" @default.
• W2054953072 title "Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers" @default.
• W2054953072 cites W166961482 @default.
• W2054953072 cites W1897802257 @default.
• W2054953072 cites W1964752664 @default.
• W2054953072 cites W1977015486 @default.
• W2054953072 cites W1977356115 @default.
• W2054953072 cites W1983961550 @default.
• W2054953072 cites W1984750597 @default.
• W2054953072 cites W1995047633 @default.
• W2054953072 cites W2004805804 @default.
• W2054953072 cites W2005288590 @default.
• W2054953072 cites W2021669258 @default.
• W2054953072 cites W2029231546 @default.
• W2054953072 cites W2032031944 @default.
• W2054953072 cites W2032554444 @default.
• W2054953072 cites W2038544543 @default.
• W2054953072 cites W2040593473 @default.
• W2054953072 cites W2051055358 @default.
• W2054953072 cites W2059568170 @default.
• W2054953072 cites W2069419271 @default.
• W2054953072 cites W2070692392 @default.
• W2054953072 cites W2074470232 @default.
• W2054953072 cites W2075549113 @default.
• W2054953072 cites W2077080337 @default.
• W2054953072 cites W2098321535 @default.
• W2054953072 cites W2098737602 @default.
• W2054953072 cites W2102392974 @default.
• W2054953072 cites W2104960492 @default.
• W2054953072 cites W2107943787 @default.
• W2054953072 cites W2111489144 @default.
• W2054953072 cites W2115585701 @default.
• W2054953072 cites W2117859020 @default.
• W2054953072 cites W2118841717 @default.
• W2054953072 cites W2119018891 @default.
• W2054953072 cites W2120570942 @default.
• W2054953072 cites W2127680641 @default.
• W2054953072 cites W2139248078 @default.
• W2054953072 cites W2152216185 @default.
• W2054953072 cites W2159207048 @default.
• W2054953072 cites W2164653269 @default.
• W2054953072 cites W2169965478 @default.
• W2054953072 cites W2404633042 @default.
• W2054953072 cites W310150161 @default.
• W2054953072 doi "https://doi.org/10.1007/s10456-012-9260-6" @default.
• W2054953072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3338912" @default.
• W2054953072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22382585" @default.
• W2054953072 hasPublicationYear "2012" @default.
• W2054953072 type Work @default.
• W2054953072 sameAs 2054953072 @default.
• W2054953072 citedByCount "58" @default.
• W2054953072 countsByYear W20549530722012 @default.
• W2054953072 countsByYear W20549530722013 @default.
• W2054953072 countsByYear W20549530722014 @default.
• W2054953072 countsByYear W20549530722015 @default.
• W2054953072 countsByYear W20549530722016 @default.
• W2054953072 countsByYear W20549530722017 @default.
• W2054953072 countsByYear W20549530722018 @default.
• W2054953072 countsByYear W20549530722019 @default.
• W2054953072 countsByYear W20549530722020 @default.
• W2054953072 countsByYear W20549530722021 @default.
• W2054953072 countsByYear W20549530722022 @default.
• W2054953072 countsByYear W20549530722023 @default.
• W2054953072 crossrefType "journal-article" @default.
• W2054953072 hasAuthorship W2054953072A5003913815 @default.
• W2054953072 hasAuthorship W2054953072A5007823301 @default.
• W2054953072 hasAuthorship W2054953072A5010799165 @default.
• W2054953072 hasAuthorship W2054953072A5022695721 @default.
• W2054953072 hasAuthorship W2054953072A5025020524 @default.
• W2054953072 hasAuthorship W2054953072A5025413217 @default.
• W2054953072 hasAuthorship W2054953072A5033055161 @default.
• W2054953072 hasAuthorship W2054953072A5046601140 @default.
• W2054953072 hasAuthorship W2054953072A5047673996 @default.
• W2054953072 hasAuthorship W2054953072A5054413273 @default.
• W2054953072 hasAuthorship W2054953072A5058514609 @default.

• next